Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epratuzumab in Rituximab-Refractory Low-Grade Follicular B-Cell Non-Hodgkin's Lymphoma
NCT00022685Phase 3Unknown
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Sep 2001
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of epratuzumab in follicular lymphoma (FL), sponsored by UCLA Jonsson Comprehensive Cancer Center. Status: unknown.
02
Drugs
epratuzumab
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00022685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00022685.